Recruiting

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(6 sites)

Japan

Ehime University Hospital, Toon-shi, Ehime

Mie University Hospital, Tsu, Mie-ken

Osaka University Hospital, Suita-shi, Osaka

Juntendo University Hospital, Bunkyo-ku, Tokyo

Tokyo Medical University Hospital, Shinjuku-ku, Tokyo

University of Yamanashi Hospital, Chuo-shi, Yamanashi